Mometasone Sandoz (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasone Sandoz, is a corticosteroid presented as a nasal spray for nasal use. It is employed to treat inflammatory conditions of the nasal passages such as allergic rhinitis and nasal polyps in adults and children. GNH USA supplies Mometasone Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate is a topical corticosteroid used in the nasal cavity to manage inflammatory nasal disorders. - Allergic rhinitis: reduces nasal congestion, itching and sneezing caused by allergens. - Nasal polyps: decreases polyp size and improves nasal airflow. - Seasonal allergic rhinitis: controls symptoms during pollen seasons by limiting inflammatory response.

Mometasone furoate may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation - Epistaxis (nosebleeds) - Headache - Altered taste or bitter taste - Throat irritation or dryness - Nasal congestion

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Vision changes or cataract formation - Adrenal suppression with prolonged use - Opportunistic fungal infection in the nasal cavity - Elevated intra‑ocular pressure leading to glaucoma

Before using Mometasone nasal spray, consider the following safety measures. - Assess for active nasal infection: avoid use if bacterial or fungal infection is present. - Use lowest effective dose: limit duration to the shortest period needed for symptom control. - Avoid prolonged continuous therapy: periodic breaks reduce risk of systemic effects. - Monitor for adrenal insufficiency: especially in children or with high‑dose regimens. - Caution in patients with glaucoma or cataracts: may exacerbate ocular pressure. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Mometasone nasal spray can interact with other medicines that affect corticosteroid metabolism or immune function.

Major Interactions (Avoid): - Systemic corticosteroids: additive immunosuppression and adrenal suppression. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir): may increase local exposure. - Immunosuppressive biologics (e.g., TNF‑α inhibitors): heightened risk of infection.

Moderate Interactions (Monitor Closely): - Antihistamines: may mask early signs of local irritation. - Nasal decongestants: concurrent use can increase nasal mucosa dryness. - Antifungal nasal preparations: monitor for overlapping irritation.